The Math

Half-Life, Clearance, and Why Your Curve Looks Different From Someone Else's

Published September 8, 2026 · Written by the Amino Minder team, based on published pharmacokinetic research

Two people can take the identical dose of the identical compound, at the identical time, and see meaningfully different plasma-level curves. That's not a modeling inconsistency — it's the expected, mathematically predictable result of individual variation in how bodies process compounds. This article looks at the two levers that actually drive that difference: half-life and clearance.

Half-life sets the baseline decay rate

Every compound has a default half-life — a starting-point estimate of how long it takes for half of an administered amount to clear the body, drawn from community usage patterns and available reference data. That default is a reasonable population-level starting point, not a guarantee about any specific individual. Real biological variation — body composition, kidney and liver function, age, and plenty of factors that aren't fully characterized for many peptides — all influence how quickly a given person actually clears a given compound.

Mathematically, half-life converts directly into an elimination rate constant via ke = ln(2) / half-life. A shorter half-life means a larger ke, which means the exponential decay term in the underlying model falls off faster — a visibly steeper drop after the peak. A longer half-life means a smaller ke and a curve that lingers.

This is why a tool that lets you adjust a compound's assumed half-life isn't a cosmetic feature — it's the single most direct way to make the model reflect what you're actually observing about your own response, rather than a population average that may not describe you specifically.

Clearance: one slider, applied everywhere at once

Half-life adjustments are compound-specific. But there's a second, broader kind of individual variation: a general tendency toward faster or slower clearance across the board, often associated with overall organ health and function. Modeling this as a single global multiplier — a "clearance modifier" — captures that broader effect without requiring you to separately tune every compound in your library by hand.

The mechanism is simple and consistent: the modifier multiplies the elimination rate directly, ke_effective = ke_base × clearance_modifier. A modifier above 1.0 means faster-than-baseline clearance across every tracked compound simultaneously; below 1.0 means slower. Because it acts on the rate constant itself, its effect compounds correctly with each compound's own half-life rather than fighting it — a compound with an already-short half-life and a high clearance modifier will show a sharper, faster curve than the same modifier applied to a naturally long-half-life compound, which is the physically sensible outcome.

Why the math treats this as a compute-time property, not a stored one

An important design consequence follows from how this modeling actually works: half-life and clearance settings are applied at the moment a curve is calculated, not baked into a stored, fixed history. That means if you adjust your clearance modifier or a compound's half-life override, every chart — including ones covering doses logged in the past — recalculates immediately to reflect the new assumption.

This is a deliberate choice, not an oversight. The alternative — locking in a curve's shape at the moment a dose was logged, then never letting it update — would mean an early, poorly-calibrated guess about your own half-life gets permanently frozen into your history, even after you've refined that estimate with more real observation. Recomputing from current assumptions keeps the whole picture internally consistent: every curve you look at, past or present, reflects your best current understanding of your own kinetics, not whatever you happened to believe on day one.

What this doesn't mean

None of this converts a modeling tool into a diagnostic one. Adjusting a half-life or clearance value changes what the model assumes about you — it isn't a measurement of your actual physiology, and no consumer tracking tool can turn a logged dose and a timestamp into a lab result. The value of making these settings adjustable isn't precision for its own sake; it's transparency. You can see exactly which two numbers are driving the shape of your curve, and change them deliberately, rather than treating the output as an unquestionable black box.

Amino Minder is a personal tracking and informational tool. This article is general educational information about pharmacokinetic modeling and is not medical advice. It is not a substitute for professional medical guidance. See our full medical disclaimer.